Literature DB >> 8041722

The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 5' splice site selection in vivo.

X Yang1, M R Bani, S J Lu, S Rowan, Y Ben-David, B Chabot.   

Abstract

Recent in vitro results suggest that the heterogeneous nuclear ribonucleoparticle (hnRNP) A1 protein modulates alternative splicing by favoring distal 5' splice site (5'SS) selection and exon skipping. We used a mouse erythroleukemia (MEL) cell line (CB3C7) deficient in the expression of hnRNP A1 to test whether variations in hnRNP A1 and AlB protein levels affected alternative splicing in vivo. In contrast to A1-expressing MEL cell lines, CB3C7 cells preferentially selected the proximal 13S and 12S 5'SS on the adenovirus E1A pre-mRNA. Transiently expressing the A1 or A1B cDNA in CB3C7 cells shifted 5'SS selection toward the more distal 9S donor site. A1 protein synthesis was required for this effect since the expression of a mutated A1 cDNA did not affect 5'SS selection. These results demonstrate that in vivo variations in hnRNP A1 protein levels can influence 5'SS selection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041722      PMCID: PMC44310          DOI: 10.1073/pnas.91.15.6924

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Crosslinking of hnRNP proteins to pre-mRNA requires U1 and U2 snRNPs.

Authors:  S H Mayrand; T Pederson
Journal:  Nucleic Acids Res       Date:  1990-06-11       Impact factor: 16.971

2.  Antibodies to hnRNP core proteins inhibit in vitro splicing of human beta-globin pre-mRNA.

Authors:  H Sierakowska; W Szer; P J Furdon; R Kole
Journal:  Nucleic Acids Res       Date:  1986-07-11       Impact factor: 16.971

3.  Heterogeneous nuclear ribonucleoproteins: role in RNA splicing.

Authors:  Y D Choi; P J Grabowski; P A Sharp; G Dreyfuss
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

4.  In vitro splicing of adenovirus E1A transcripts: characterization of novel reactions and of multiple branch points abnormally far from the 3' splice site.

Authors:  R Gattoni; P Schmitt; J Stevenin
Journal:  Nucleic Acids Res       Date:  1988-03-25       Impact factor: 16.971

5.  Isolation of an active gene encoding human hnRNP protein A1. Evidence for alternative splicing.

Authors:  G Biamonti; M Buvoli; M T Bassi; C Morandi; F Cobianchi; S Riva
Journal:  J Mol Biol       Date:  1989-06-05       Impact factor: 5.469

6.  Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus.

Authors:  Y Ben-David; E B Giddens; A Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  RNA binding specificity of hnRNP proteins: a subset bind to the 3' end of introns.

Authors:  M S Swanson; G Dreyfuss
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

8.  A novel adenovirus-2 E1A mRNA encoding a protein with transcription activation properties.

Authors:  P J Ulfendahl; S Linder; J P Kreivi; K Nordqvist; C Sevensson; H Hultberg; G Akusjärvi
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

9.  Alternative splicing in the human gene for the core protein A1 generates another hnRNP protein.

Authors:  M Buvoli; F Cobianchi; M G Bestagno; A Mangiarotti; M T Bassi; G Biamonti; S Riva
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

10.  Differential splicing yields novel adenovirus 5 E1A mRNAs that encode 30 kd and 35 kd proteins.

Authors:  C Stephens; E Harlow
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more
  101 in total

1.  The levels of the bancal product, a Drosophila homologue of vertebrate hnRNP K protein, affect cell proliferation and apoptosis in imaginal disc cells.

Authors:  B Charroux; C Angelats; L Fasano; S Kerridge; C Vola
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Identification and characterization of a novel serine-arginine-rich splicing regulatory protein.

Authors:  D C Barnard; J G Patton
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

3.  Evaluation of the role of heterogeneous nuclear ribonucleoprotein A1 as a host factor in murine coronavirus discontinuous transcription and genome replication.

Authors:  X Shen; P S Masters
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

4.  Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization.

Authors:  M Blanchette; B Chabot
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

Review 5.  RNA-protein interactions that regulate pre-mRNA splicing.

Authors:  Ravinder Singh
Journal:  Gene Expr       Date:  2002

6.  Interaction between hnRNPA1 and IkappaBalpha is required for maximal activation of NF-kappaB-dependent transcription.

Authors:  D C Hay; G D Kemp; C Dargemont; R T Hay
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

7.  Regulation of alternative splicing by SRrp86 through coactivation and repression of specific SR proteins.

Authors:  Daron C Barnard; Jun Li; Rui Peng; James G Patton
Journal:  RNA       Date:  2002-04       Impact factor: 4.942

8.  Control of hnRNP A1 alternative splicing: an intron element represses use of the common 3' splice site.

Authors:  M J Simard; B Chabot
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

9.  Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch.

Authors:  Victor C Hou; Robert Lersch; Sherry L Gee; Julie L Ponthier; Annie J Lo; Michael Wu; Chris W Turck; Mark Koury; Adrian R Krainer; Akila Mayeda; John G Conboy
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

10.  Multiple interdependent sequence elements control splicing of a fibroblast growth factor receptor 2 alternative exon.

Authors:  F Del Gatto; A Plet; M C Gesnel; C Fort; R Breathnach
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.